12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sun, 28 Dec 2025 20:42:29 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6InVtUTJLbHkxOVFyWHBBdVZ4SSttdkE9PSIsInZhbHVlIjoiNklCZkdJbERKenZmVkNCVVBFQXdrQmkwSWhpT2xnNHlaaVpDNzgxbkNPMCtjVkJ5cXRDckJvSjU0dVlxaUxlTURlamcrSWwwd3k4bStlcnk3YmxPXC93PT0iLCJtYWMiOiIxNGQyNjAyZWQzYjc4MmM4YjgxYWM2ZjJiZWQ3MWEwYWU0NjlhYmFjMWQ1MGI1ZjQ0OGQ5NDRhY2VkZmIxODM3In0%3D; expires=Wed, 27-Dec-2028 20:42:28 GMT; Max-Age=94608000; path=/; HttpOnly [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Mon, 29 Dec 2025 20:42:28 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=SWvtFGm2s8tEYYNa%2FCLAjkNVR%2BibS6PDyCwlqadNJ8vBnR%2BmG7EqmWA%2FI367clxmOewkhzpvalDM5dUPNB9%2BGAI3omJ6VDy2Lg0b7wIWYw%3D%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [21] => Speculation-Rules: "/cdn-cgi/speculation" [22] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [23] => Server-Timing: cfEdge;dur=7,cfOrigin;dur=839 [24] => CF-RAY: 9b53e2669d84f514-LAX [25] => alt-svc: h3=":443"; ma=86400 ) 789

 

 

据《泰叻报》等多家主流媒体报道，泰国公共卫生部周日召开新闻发布会透露，叻威提（Rajavithi）医院专家团队发现了可有效治疗新型冠状病毒感染肺炎（武汉肺炎）的药方，重症患者用药48小时后，检测结果为阴性。

公共卫生部指出，叻威提医院专家团队将抑制流感病毒的药物奥司他韦（Oseltamivir），与抗艾滋药物配合使用在武汉肺炎重症患者身上，12小时内患者病情明显好转，48小时内病毒检测结果就变成了阴性。

卫生部指出，曾经连续10天检测呈阳性的患者，在使用该药方后，检测结果成功转为阴性，目前患者体内已经没有新型冠状病毒。该药方见效快，病人使用后恢复也很快，这是抗击‘武汉肺炎’征程上的一个好消息。

而叻威提医院专家团队所用的两种药物，均是泰国政府制药组织（The Government Pharmaceutical Organization）自行生产的。

---

// // // //